BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16312637)

  • 1. Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
    Brückner O; Trautmann M
    J Chemother; 1989 Jul; 1(4 Suppl):782-3. PubMed ID: 16312637
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefixime: comparative clinical trial on the treatment of lower respiratory tract infection in adults.
    Catena E; Mistretta A; Micillo E; Crimi N; Dericoloso L; Tranchese D; Barbagallo S
    J Chemother; 1989 Jul; 1(4 Suppl):786-8. PubMed ID: 16312639
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of respiratory tract infections with augmentin.
    Cioffi R; Turco D; Alfano B; Di Salvatore F; Gnasso P; Mastroianni S
    J Chemother; 1989 Jul; 1(4 Suppl):766-7. PubMed ID: 16312630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease].
    Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (12):13-6. PubMed ID: 15719658
    [No Abstract]   [Full Text] [Related]  

  • 5. Cefixime once-a-day in the treatment of lower respiratory tract infections in adults.
    Capelli O; Bonucchi ME; Ragno T; Azzolini L; Prandi E; Lega M; Toraldo MD; Velluti G
    J Chemother; 1989 Jul; 1(4 Suppl):775-8. PubMed ID: 16312634
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.
    Kobayashi H
    Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
    Esposito S; Galante D; Bianchi W; Gagliardi R
    Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [15th Consensus Conference on anti-infectious treatments: management of viral infections of the lower respiratory tract in the immunocompetent adult. Short text].
    ; ; ; ; ; ; ; ;
    Rev Pneumol Clin; 2007 Feb; 63(1):7-18. PubMed ID: 17457279
    [No Abstract]   [Full Text] [Related]  

  • 9. [How long the antibiotic treatment should be for pulmonary infections?].
    Murris-Espin M
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S83-10S84. PubMed ID: 17127974
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract].
    Chuchalin AG; Novikov IuK; Avdeev SN; Belevskiĭ AS
    Antibiot Khimioter; 1997; 42(6):34-8. PubMed ID: 9313057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ofloxacin versus amoxicillin in the treatment of lower respiratory tract infections. A multicenter prospective clinical trial.
    Chuard C; Regamey C
    J Chemother; 1989 Jul; 1(4 Suppl):784-5. PubMed ID: 16312638
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefixime: comparative clinical trial on the treatment of upper respiratory tract infection and otitis in adults.
    Puxeddu P; Cadoni BM; Cadeddu L
    J Chemother; 1989 Jul; 1(4 Suppl):780-2. PubMed ID: 16312636
    [No Abstract]   [Full Text] [Related]  

  • 13. [Levofloxacin and other fluoroquinolones in therapy of respiratory tract infections].
    Płusa T
    Pol Merkur Lekarski; 2011 Feb; 30(176):91-6. PubMed ID: 21544977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bronchopulmonary infections by ciprofloxacin in an intensive care unit. Correlation between serum and bronchial concentrations and bacteriological results.
    Beuscart C; Leroy O; Chidiac C; Houriez S; Caillaux M; Beaucaire G; Mouton Y
    J Chemother; 1989 Jul; 1(4 Suppl):794-6. PubMed ID: 16312643
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced antibiotic pressure for the treatment of acute exacerbation of chronic obstructive pulmonary disease: back to the future.
    Fantin B
    Clin Infect Dis; 2010 Jul; 51(2):150-2. PubMed ID: 20536365
    [No Abstract]   [Full Text] [Related]  

  • 16. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
    Sollet JP
    Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S113-4. PubMed ID: 16904296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral treatment of gonorrhea and chlamydia.
    Loughlin KA; Bakst CM; Rybak MJ
    Ann Pharmacother; 1994 May; 28(5):600-2. PubMed ID: 8068998
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM; Davis NB; Wu SC; Kahn J
    Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the therapeutic uses of ofloxacin.
    Giamarellou H; Kanellakopoulou K
    J Chemother; 1989 Jul; 1(4 Suppl):670-2. PubMed ID: 16312585
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of lower respiratory tract infections in immunocompetent adults (community-acquired pneumonia and acute exacerbation of chronic obstructive pulmonary disease): The challenge of a new consensus conference].
    Chidiac C
    Med Mal Infect; 2006; 36(11-12):535-7. PubMed ID: 17137740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.